#United States #Los Angeles #Breast Cancer #City of Hope #RevitaLash

RevitaLash® Cosmetics Makes History with New Research Grant

RevitaLash® Cosmetics, recognized worldwide for its pioneering innovations in lash and brow care, recently set a new precedent in funding cancer research. The company unveiled the Gayle Brinkenhoff Excellence in Cancer Research Award, which encompasses a substantial two-year grant amounting to $286,000. This vital financial support is directed towards advancing the understanding and treatment of breast cancer at City of Hope, one of America’s leading cancer research facilities.

The Significance of the Grant

This grant, which marks the largest allocation in RevitaLash® Cosmetics’ history, aims to propel significant research led by Dr. Jeff Perry. Dr. Perry and his team are set to focus on groundbreaking treatments that will ultimately contribute to better patient care and outcomes for those battling breast cancer. The financial backing is especially timely, as it complements the mission of City of Hope, which has been at the forefront of cancer treatment and research since its establishment in 1913.

Annual Symposium: A Platform for Collaboration

Coinciding with the announcement, the 10th Annual Gayle Brinkenhoff Breast Cancer Symposium took place on November 20 at City of Hope’s Los Angeles campus. This event gathered preeminent researchers, oncologists, and industry innovators from various prestigious institutions, all focused on one goal: to foster collaboration and innovation in breast cancer research. This year’s symposium tackled the critical issue of metastasis—exploring ways to prevent and treat this condition to enhance survival rates for women affected by metastatic breast cancer.

The symposium featured a series of presentations aimed at sharing the latest breakthroughs in the field and igniting discussions that could lead to transformative ideas and partnerships.

Honoring Legacy and Fostering Innovation

The event is not only a testament to the legacy of RevitaLash® Co-Founder Gayle Brinkenhoff but also a beacon of hope for the future of breast cancer treatment. For the first time, this year’s symposium saw an additional partnership through sponsorship from Menarini Stemline, further emphasizing the collaborative spirit necessary to tackle such an important health issue.

A Commitment to Research and Innovation

RevitaLash® Cosmetics is steadfast in its commitment to supporting research through grants and philanthropy, key components of the company’s mission. Dr. Perry's lab will utilize the grant to advance their innovative studies surrounding PCNA protein—a crucial player in DNA repair and genome stability. The ultimate objective of this research is to uncover novel cancer therapies tailored to vulnerable targets, previously deemed undruggable.

Dr. Perry expressed gratitude upon receiving the award, stating that these funds will significantly enhance their ability to explore therapies that could revolutionize treatment for patients. He highlighted the goal of turning research discoveries into tangible treatments with the power to improve patient outcomes.

Linda Malkas, Ph.D., from City of Hope, noted the unique space created by the symposium, praising RevitaLash® Cosmetics for their unwavering support that allows for crucial collaboration among experts.

Looking Towards the Future

Michael Brinkenhoff, CEO of RevitaLash® Cosmetics, further emphasized the brand's dedication to fostering research and innovation that could lead to life-changing treatments for breast cancer. He reiterated the company’s commitment to philanthropy and the importance of supporting ongoing efforts through events like the Gayle Brinkenhoff Breast Cancer Symposium.

For more insights on RevitaLash® Cosmetics' philanthropic initiatives surrounding breast cancer and the impact your purchases can make, visit RevitaLash's official website.

About RevitaLash® Cosmetics

Founded in 2006, RevitaLash® Cosmetics is a leader in the design of advanced beautification products for lashes, brows, and hair. The company’s dedication to charitable causes, particularly breast cancer initiatives, highlights their commitment to giving back year-round, extending beyond traditional awareness months. Their collection, which includes the award-winning RevitaLash® Advanced Eyelash Conditioner, enjoys a global presence, catering to beauty needs across over 70 countries.

About City of Hope

City of Hope operates as one of the largest cancer research and treatment centers in the United States, distinguished by its National Cancer Institute-designated comprehensive cancer center. Their integrated model encompasses cutting-edge cancer care, research, education, and a robust philanthropy program, driving advancements in cancer treatment and care across the nation.